ClinConnect ClinConnect Logo
Search / Trial NCT02663388

Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection)

Launched by UNIVERSITY OF LORRAINE · Jan 20, 2016

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Epigenetic Mechanisms and Severe Obesity," is studying how vitamin levels and genetic changes (called epigenetic mechanisms) affect serious complications related to obesity, diabetes, and liver disease. The researchers are looking to understand these factors better to help improve treatments for people struggling with severe obesity.

To participate in this study, you need to be between the ages of 65 and 74 and have a body mass index (BMI) of over 35, which means you may be eligible for weight-loss surgery known as bariatric surgery. If you join the trial, you can expect to provide biological samples, like blood or tissue, to help researchers learn more about the connection between your vitamin levels and obesity-related issues. It's important to know that participants must be able to understand the information about the study and agree to take part by signing a consent form. This study is currently recruiting participants, so if you or someone you know fits the criteria and is interested, this could be a valuable opportunity to contribute to important medical research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • indication for bariatric surgery with BMI \> 35 kg/m2
  • Exclusion Criteria:
  • unable to receive clear information
  • refusal to sign the consent form

About University Of Lorraine

The University of Lorraine is a prestigious academic institution in France, recognized for its commitment to advancing research and innovation in various fields, including health sciences. With a strong emphasis on interdisciplinary collaboration, the university conducts clinical trials aimed at improving patient outcomes and contributing to the global body of medical knowledge. Its research initiatives are supported by state-of-the-art facilities and a network of experienced professionals dedicated to ethical practices and rigorous scientific standards. The University of Lorraine is dedicated to fostering a robust research environment that promotes the translation of scientific discoveries into clinical applications, ultimately enhancing healthcare delivery.

Locations

Vandoeuvre Les Nancy, , France

Patients applied

0 patients applied

Trial Officials

laurent BRUNAUD, MD, PhD

Principal Investigator

University of Lorraine, CHU Nancy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials